InvestorsHub Logo
Followers 0
Posts 29
Boards Moderated 0
Alias Born 05/07/2019

Re: None

Wednesday, 09/02/2020 2:15:01 PM

Wednesday, September 02, 2020 2:15:01 PM

Post# of 44690
Got this from Reddit then confirmed it for myself.

RLFTF - "Insider News" New Study in Switzerland for COVID-19 ARDS PREVENTION with Inhalator
Catalyst
! This news is new and has not yet published by Press or Press Releases

First draft of a Study for Inhaled version of RLF-100 was published on Clinicaltrials for a study to Prevent COVID-19 effects with a Inhaler administered drug(Goal is that people can treat themselves at home). The Study is to be conducted in Switzerland and will compliment the same study in the US. The swiss study focuses on the preventive character of the drug.

RLF previously mentioned a Phase 3 study in Europe without more specific information.

https://clinicaltrials.gov/ct2/show/NCT04536350 (Seems to be a draft)

RLFTF already has it's IV COVID-19 drug in clinical trials and it is seen as the most effective COVID-19 treatment in clinical trials, further information: https://www.reddit.com/r/investing/comments/ihjz24/rlftf_the_most_promising_covid19_stock_drug/




insert-text-here